Showing 1 - 3 results of 3 for search 'P. Lovat', query time: 0.02s Refine Results
  1. 1
    Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis

    Loss of AMBRA1 expression in the tumour endothelium as a potential biomarker to identify AJCC stage I/II melanomas at high risk of metastasis by P. Lovat, R. Stout, K. Best, P. Sloan, J. Armstrong

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Immunohistochemical analysis of AMBRA1 and loricrin expression reveals maintained expression in the epidermis overlying a range of benign melanocytic naevi but which may be altered in some melanoma in situ cases

    Immunohistochemical analysis of AMBRA1 and loricrin expression reveals maintained expression in the epidermis overlying a range of benign melanocytic naevi but which may be altered... by A. Husain, P. Lovat, G. Richardson, T. Ness, C. Jones, C. Graham, M. Labus, P. Sloan

    Published 2024-01-01
    Get full text
    Article
  3. 3
    AMBRA1 is a predictive biomarker of melanoma response to targeted therapy

    AMBRA1 is a predictive biomarker of melanoma response to targeted therapy by L. Di Leo, C. Pagliuca, A. Kishk, S. Rizza, C. Tsiavou, C. Pecorari, C. Dahl, M. Pacheco, R. Tholstrup, J. Brewer, P. Berico, E. Hernando, F. Cecconi, R. Ballotti, C. Bertolotto, G. Filomeni, M. Gjerstorff, T. Sauter, P. Lovat, P. Guldberg, D. De Zio

    Published 2024-01-01
    Get full text
    Article

Search Tools: